Awny Farajallah | Chief Medical Officer

Awny Farajallah, M.D. is the chief medical officer for Takeda.

Awny joined Takeda in July 2021 as the head of Global Medical Affairs Oncology. He is a strategic leader with over 25 years of combined experience in both academic and industry settings related to clinical research/development and medical affairs across multiple therapeutic areas.

Before joining Takeda, Awny worked at Ipsen, where he was senior vice president, Medical Affairs, North America. During his tenure, he led efforts to enhance Medical Affairs capabilities with the goal of broadening the impact on patients through medical stakeholder partnerships across Oncology, Neuroscience and Rare Disease.

Prior to Ipsen, Awny served as vice president and head of U.S. Medical Affairs at Bristol Myers Squibb, where he led functions such as field medical, disease areas, medical education, biomarkers, promotional material review, portfolio strategy, as well as strategic collaborations across oncology, immunoscience, cardiovascular and neurology. Awny led multiple successful launches in immuno-oncology and hematology, was the clinical development lead for hematological malignancies in leukemia and multiple myeloma and led the global medical and clinical development teams for HIV.

Awny earned his M.D. from Cairo University and completed an Internal Medicine residency and Infectious Diseases fellowship at the University of Arkansas for Medical Sciences and New Jersey Medical School, respectively.